RMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis

Background: visceral leishmaniasis (VL) is a critical public health problem in over ninety countries. The control measures adopted in Brazil have been insufficient when it comes to preventing the spread of this overlooked disease. In this context, a precise diagnosis of VL in dogs and humans could help to reduce the number of cases of this disease. Distinct studies for the diagnosis of VL have used single recombinant proteins in serological assays; however, the results have been variable, mainly in relation to the sensitivity of the antigens. In this context, the development of multiepitope-based proteins could be relevant to solving such problem.

Methods: a chimeric protein (rMELEISH) was constructed based on amino acid sequences from kinesin 39 (k39), alpha-tubulin, and heat-shock proteins HSP70 and HSP 83.1, and tested in enzyme-linked immunosorbent (ELISA) for the detection of infection using canine ( = 140) and human ( = 145) sera samples.

Results: in the trials, rMELEISH was able to discriminate between VL cases and cross-reactive diseases and healthy samples, with sensitivity and specificity values of 100%, as compared to the use of a soluble Leishmania antigenic extract (SLA).

Conclusions: the preliminary data suggest that rMELEISH has the potential to be tested in future studies against a larger serological panel and in field conditions for the diagnosis of canine and human VL.

Citing Articles

Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review.

Resende C, Ribeiro A, Gandra I, Silva K, Lopes L, Barcelos I Front Microbiol. 2024; 15:1420226.

PMID: 39139374 PMC: 11319188. DOI: 10.3389/fmicb.2024.1420226.

Recombinant multiepitope proteins expressed in Escherichia coli cells and their potential for immunodiagnosis.

Goncalves A, Ribeiro A, Resende C, Couto C, Gandra I, Barcelos I Microb Cell Fact. 2024; 23(1):145.

PMID: 38778337 PMC: 11110257. DOI: 10.1186/s12934-024-02418-w.

References

Laurenti M, Rossi C, Matta V, Tomokane T, Corbett C, Secundino N . Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector. Vet Parasitol. 2013; 196(3-4):296-300. DOI: 10.1016/j.vetpar.2013.03.017. View

Thomasini R, Souza H, Bruna-Romero O, Totola A, Goncales N, Lima C . Evaluation of a recombinant multiepitope antigen for diagnosis of hepatitis C virus: A lower cost alternative for antigen production. J Clin Lab Anal. 2018; 32(6):e22410. PMC: 6816884. DOI: 10.1002/jcla.22410. View

Rico A, Girones N, Fresno M, Alonso C, Requena J . The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones. 2003; 7(4):339-46. PMC: 514833. DOI: 10.1379/1466-1268(2002)007<0339:thspha>2.0.co;2. View

Grimaldi Jr G, Teva A, Ferreira A, Dos Santos C, Pinto I, de-Azevedo C . Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2011; 106(1):54-9. DOI: 10.1016/j.trstmh.2011.10.001. View

Howard M, Gull K, Miles M . Antibodies to tubulin in patients with parasitic infections. Clin Exp Immunol. 1987; 68(1):78-85. PMC: 1542701. View

Quijada L, Requena J, Soto M, Alonso C . Analysis of the antigenic properties of the L. infantum Hsp70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis. Immunol Lett. 1998; 63(3):169-74. DOI: 10.1016/s0165-2478(98)00071-6. View

Badaro R, Benson D, Eulalio M, Freire M, Cunha S, Netto E . rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis. 1996; 173(3):758-61. DOI: 10.1093/infdis/173.3.758. View

Lage D, Ribeiro P, Dias D, Mendonca D, Ramos F, Carvalho L . A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against infection. NPJ Vaccines. 2020; 5:75. PMC: 7426426. DOI: 10.1038/s41541-020-00224-0. View

Burns Jr J, Shreffler W, Benson D, Ghalib H, Badaro R, Reed S . Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A. 1993; 90(2):775-9. PMC: 45748. DOI: 10.1073/pnas.90.2.775. View

10.

Vale D, Lage D, Machado A, Freitas C, de Oliveira D, Galvani N . Serodiagnosis of canine leishmaniasis using a novel recombinant chimeric protein constructed with distinct B-cell epitopes from antigenic Leishmania infantum proteins. Vet Parasitol. 2021; 296:109513. DOI: 10.1016/j.vetpar.2021.109513. View

11.

Ferraz Coelho E, Tavares C, Carvalho F, Chaves K, Teixeira K, Rodrigues R . Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun. 2003; 71(7):3988-94. PMC: 162020. DOI: 10.1128/IAI.71.7.3988-3994.2003. View

12.

Safavi A, Kefayat A, Sotoodehnejadnematalahi F, Salehi M, Modarressi M . Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. Int Immunopharmacol. 2019; 76:105872. DOI: 10.1016/j.intimp.2019.105872. View

13.

Solano-Gallego L, Villanueva-Saz S, Carbonell M, Trotta M, Furlanello T, Natale A . Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT. Parasit Vectors. 2014; 7:111. PMC: 3994334. DOI: 10.1186/1756-3305-7-111. View

14.

Kelley L, Mezulis S, Yates C, Wass M, Sternberg M . The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015; 10(6):845-58. PMC: 5298202. DOI: 10.1038/nprot.2015.053. View

15.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

16.

Freire M, de Souza A, Cota G, Rabello A, Assis T . Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario. PLoS Negl Trop Dis. 2020; 14(10):e0008741. PMC: 7544087. DOI: 10.1371/journal.pntd.0008741. View

17.

Ozbel Y, Turgay N, Ozensoy S, Ozbilgin A, Alkan M, Ozcel M . Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol. 1995; 89 Suppl 1:89-93. DOI: 10.1080/00034983.1995.11813018. View

18.

Yin D, Bai Q, Li L, Xu K, Zhang J . Study on immunogenicity and antigenicity of a novel brucella multiepitope recombined protein. Biochem Biophys Res Commun. 2021; 540:37-41. DOI: 10.1016/j.bbrc.2020.12.098. View

19.

Sundar S, Rai M . Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol. 2002; 9(5):951-8. PMC: 120052. DOI: 10.1128/cdli.9.5.951-958.2002. View

20.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View